Twice-Daily versus Once-Daily Pramipexole Extended Release Dosage Regimens in Parkinson's Disease

This open-label study aimed to compare once-daily and twice-daily pramipexole extended release (PER) treatment in Parkinson's disease (PD). PD patients on dopamine agonist therapy, but with unsatisfactory control, were enrolled. Existing agonist doses were switched into equivalent PER doses. Su...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Parkinsons Dis
Huvudupphovsmän: Yun, Ji Young, Kim, Young Eun, Yang, Hui-Jun, Kim, Han-Joon, Jeon, Beomseok
Materialtyp: Artigo
Språk:Inglês
Publicerad: Hindawi Publishing Corporation 2017
Ämnen:
Clinical Study
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5318624/
https://ncbi.nlm.nih.gov/pubmed/28265478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8518929
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk